Skip to main content
Premium Trial:

Request an Annual Quote

Mark Crane, Nicholas Ventresca, Frantisek Svec, GE Healthcare



Gene Logic last week appointed Mark Crane as vice president of marketing and business development for the company's preclinical division. Crane previously held marketing positions at Quest Pharmaceutical Services, MDS Pharma Services, Avantec, and PerkinElmer. In his new position with Gene Logic, Crane will be responsible for sales and marketing of preclinical services to pharmaceutical and biotechnology companies, as well as government organizations.

Charles River Laboratories has appointed Nicholas Ventresca as corporate senior vice president of information technology and chief information officer. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn. He also served as CIO of Warner-Lambert's Schick & Wilkinson Sword group and CTO of Pepsi-Cola.

Frantisek Svec has joined the scientific advisory board of Protein Discovery, the company announced last week.

Svec is known for his contributions to the development of the monolithic chromatography column. He is presently working at the University of California Berkeley and the Lawrence Berkeley National Laboratory, where he continues to investigate the synthesis of new separations media for use in both conventional and microscale chromatography systems.

Svec received a PhD in polymer chemistry and a BS in chemistry from the Institute of Chemical Technology in Prague.


New Releases

GE Healthcare this week launched two GenomiPhi products, the Illustra GenomiPhi HY and Illustra GenomiPhi V2 DNA-amplification kits, both of which are designed to prepare "large quantities" of genomic DNA from "minimal" starting materials, the company said in a statement. The GenomiPhi HY kit is a midi-scale DNA prep kit for as much as 50 µg in a 4-hour reaction, while the GenomiPhi V2 is intended for small-scale DNA preps, providing smaller amounts of DNA in approximately 90 minutes, GE said.

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.